CervoMed Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -15.5% | +5.2% | +141.2% | +36.9% | -27.9% | +378.6% | -98.5% | +206.5% | +168.3% | +62.4% | -11.3% | +5.4% | -9.5% | -72.0% | – | – | – | |
| – | – | – | – | – | – | – | +761.2% | – | – | -41.0% | -27.8% | -63.0% | – | – | – | – | +26.9% | +21.9% | -62.8% | +22.1% | +244.9% | +3.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4,957.1% | – | – | – | |
| – | – | – | +142.1% | +26.3% | -101.7% | – | +116.6% | -91.2% | +5,509.6% | -38.2% | -226.8% | – | +112.2% | -277.5% | – | – | +47.7% | -75.7% | +6.6% | -168.8% | – | – | |
| – | +53.3% | -100.0% | – | – | – | – | +1,115.3% | +816.7% | -100.0% | – | – | -20.9% | -94.2% | +19,111.6% | -100.0% | – | – | – | – | +200.0% | +0.0% | -100.0% | |
| – | +57.3% | – | – | – | – | – | +549.6% | -28.8% | – | – | – | – | +245.5% | -105.3% | – | – | – | – | -305,993.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.6% | -99.2% | – | – | – | +150.6% | +165.1% | +289.5% | -65.5% | -75.1% | +2,623.7% | -92.2% | -23.5% | +1,002.3% | -51.0% | +62.6% | +11.5% | +86.1% | -100.0% | +222,882.3% | +316.2% | -90.1% | |
| – | – | – | – | – | – | -232.5% | – | – | +117.0% | -126.7% | – | -101.6% | – | – | -112.3% | – | -29.9% | +333.3% | -276.7% | – | -67.4% | -163.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.